Oligomerix, Inc.
PrivateLast Round
Grant
Nov 18, 2023
Total Funding Raised
$14.64M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oligomerix, Inc. is a clinical-stage biotechnology company that develops oral, small molecule therapeutics for neurodegenerative diseases such as Alzheimer's by targeting the aggregation of the tau protein.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oligomerix, Inc. Comparables
Compare Oligomerix, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Treventis Corporation | 86% | |
| Asceneuron | 84% | |
| Alzprotect | 81% | |
Oligomerix, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 18, 2023 | ||||
| Grant | Aug 9, 2022 | ||||
| Series B Extension | Jun 2, 2022 | ||||
| Grant | Sep 15, 2020 | ||||
| Series B | May 22, 2013 | ||||
Series A | Apr 23, 2012 |
Oligomerix, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wheatley Partners | Series A |
| NIH RADx | Grant |
| National Institute on Aging | Grant |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 63% MoM, reaching 1.5K.
- Jan 26, 2026
Monthly visitors grew 286% MoM, from 235 to 906.
Oligomerix, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oligomerix, Inc.'s valuation, stock price, and market status.